These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22089939)

  • 21. Heparin binding assay of von Willebrand factor (vWF) in plasma milieu--evidence of the importance of the multimerization degree of vWF.
    de Romeuf C; Mazurier C
    Thromb Haemost; 1993 May; 69(5):436-40. PubMed ID: 8322266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant von Willebrand factor-insight into structure and function through infusion studies in animals with severe von Willebrand disease.
    Schwarz HP; Schlokat U; Mitterer A; Váradi K; Gritsch H; Muchitsch EM; Auer W; Pichler L; Dorner F; Turecek PL
    Semin Thromb Hemost; 2002 Apr; 28(2):215-26. PubMed ID: 11992244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor.
    Turecek PL; Siekmann J; Schwarz HP
    Semin Thromb Hemost; 2002 Apr; 28(2):149-60. PubMed ID: 11992238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interventional thermal injury of the arterial wall: unfolding of von Willebrand factor and its increased binding to collagen after 55 degrees C heating.
    Post MJ; de Graaf-Bos AN; Posthuma G; de Groot PG; Sixma JJ; Borst C
    Thromb Haemost; 1996 Mar; 75(3):515-9. PubMed ID: 8701418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement of von Willebrand factor-FVIII binding activity in patients with suspected von Willebrand disease type 2N: application of an ELISA-based assay in a reference laboratory.
    Zhukov O; Popov J; Ramos R; Vause C; Ruden S; Sferruzza A; Dlott J; Sahud M
    Haemophilia; 2009 May; 15(3):788-96. PubMed ID: 19298374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of galectin-1 and galectin-3 as novel partners for von Willebrand factor.
    Saint-Lu N; Oortwijn BD; Pegon JN; Odouard S; Christophe OD; de Groot PG; Denis CV; Lenting PJ
    Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):894-901. PubMed ID: 22267483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.
    Casonato A; Pontara E; Dannhäuser D; Bertomoro A; Sartori MT; Girolami A
    Haematologia (Budap); 1994; 26(2):97-109. PubMed ID: 7890268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.
    Weiss HJ; Pietu G; Rabinowitz R; Girma JP; Rogers J; Meyer D
    J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomedicine. Contact--how platelets touch von Willebrand factor.
    Sadler JE
    Science; 2002 Aug; 297(5584):1128-9. PubMed ID: 12183613
    [No Abstract]   [Full Text] [Related]  

  • 30. [Von Willebrand factor and platelet adhesion to the subendothelium of the vascular wall].
    Meyer D
    Nouv Rev Fr Hematol (1978); 1982; 24(3):145-51. PubMed ID: 6752879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure and function of a recombinant von Willebrand factor drug candidate.
    Turecek PL; Schrenk G; Rottensteiner H; Varadi K; Bevers E; Lenting P; Ilk N; Sleytr UB; Ehrlich HJ; Schwarz HP
    Semin Thromb Hemost; 2010 Jul; 36(5):510-21. PubMed ID: 20635317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An experimental model for testing von Willebrand factor function: successful SLA-matched crossed bone marrow transplantations between normal and von Willebrand pigs.
    Roussi J; Samama M; Vaiman M; Nichols T; Pignaud G; Bonneau M; Sigman J; de Castro H; Griggs T; Drouet L
    Exp Hematol; 1996 Apr; 24(5):585-91. PubMed ID: 8605962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. von Willebrand factor conformation and adhesive function is modulated by an internalized water molecule.
    Celikel R; Ruggeri ZM; Varughese KI
    Nat Struct Biol; 2000 Oct; 7(10):881-4. PubMed ID: 11017197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. von Willebrand factor sialylation-A critical regulator of biological function.
    Ward S; O'Sullivan JM; O'Donnell JS
    J Thromb Haemost; 2019 Jul; 17(7):1018-1029. PubMed ID: 31055873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the essential intramolecular interaction between the A1 and A2 domains of von Willebrand factor.
    Karoulia Z; Papadopoulos G; Nomikos M; Thanassoulas A; Papadopoulou TC; Nounesis G; Kontou M; Stathopoulos C; Leonidas DD
    Protein Pept Lett; 2013 Feb; 20(2):231-40. PubMed ID: 22973838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenesis and classification of von Willebrand disease.
    Ruggeri ZM
    Haemostasis; 1994; 24(5):265-75. PubMed ID: 7843637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure and dynamics of the platelet integrin-binding C4 domain of von Willebrand factor.
    Xu ER; von Bülow S; Chen PC; Lenting PJ; Kolšek K; Aponte-Santamaría C; Simon B; Foot J; Obser T; Schneppenheim R; Gräter F; Denis CV; Wilmanns M; Hennig J
    Blood; 2019 Jan; 133(4):366-376. PubMed ID: 30305279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. von Willebrand factor and cancer: a renewed interest.
    Franchini M; Frattini F; Crestani S; Bonfanti C; Lippi G
    Thromb Res; 2013 Apr; 131(4):290-2. PubMed ID: 23394808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The plasma von Willebrand factor O-glycome comprises a surprising variety of structures including ABH antigens and disialosyl motifs.
    Canis K; McKinnon TA; Nowak A; Panico M; Morris HR; Laffan M; Dell A
    J Thromb Haemost; 2010 Jan; 8(1):137-45. PubMed ID: 19874459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of a new commercial von Willebrand factor multimer assay.
    Favaloro EJ; Oliver S
    Haemophilia; 2017 Jul; 23(4):e373-e377. PubMed ID: 28497866
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.